Demand for Antimicrobial Susceptibility Testing in USA
Key Insight
The demand for antimicrobial susceptibility testing in USA is projected to grow from USD 1.3 billion in 2025 to USD 1.8 billion by 2035, at a CAGR of 3.4%. Instruments will dominate with a 40.0% market share, while sepsis will lead the application segment with a 17.0% share.